Brief: Prometheus Biosciences Says Co Entered Into An Open Market Sale Agreement With Jefferies
01/04/2022 22:34
April 1 (Reuters) - Prometheus Biosciences Inc RXDX.O :
* PROMETHEUS BIOSCIENCES INC - ON APRIL 1, 2022, CO ENTERED
INTO
AN OPEN MARKET SALE AGREEMENT WITH JEFFERIES LLC - SEC FILING
* PROMETHEUS BIOSCIENCES - PURSUANT TO AGREEMENT CO MAY
OFFER AND
SELL SHARES OF COMMON STOCK OF UP TO $150.0 MILLION
Further company coverage: RXDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Prometheus Biosciences
See all newsBrief: Prometheus Biosciences - Completed Merger Of Splash Merger Sub, Unit Of Merck & Co
Analysis: Amgen's antitrust woes spur wider pharmaceutical deal fears
William Blair sees FTC suit on Amgen-Horizon deal weighing on biotech M&A sentiment
FTC scrutiny to block Amgen-Horizon deal drags down Seagen, Prometheus
Brief: Prometheus Biosciences Reports First Quarter 2023 Financial Results